Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 3/20 | 0.41 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.40 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | FABP4 | P15090 | 1/20 | 0.40 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22700909 | 0.98 | ALDH1A1 (0.47) | APEX1ALDH1A1NPSR1TSHRMEN1 | |
| SCHEMBL22700966 | 0.98 | ALDH1A1 (0.47) | APEX1ALDH1A1NPSR1TSHRMEN1 | |
| SCHEMBL22700911 | 0.98 | ALDH1A1 (0.47) | APEX1ALDH1A1NPSR1TSHRMEN1 | |
| SCHEMBL22700964 | 0.98 | ALDH1A1 (0.47) | APEX1ALDH1A1NPSR1TSHRMEN1 | |
| SCHEMBL22367632 | 0.94 | APEX1 (0.47) | APEX1ALDH1A1NPSR1TSHRMEN1 | |
| SCHEMBL28630878 | 0.80 | RGS4 (0.31) | — | |
| SCHEMBL6421284 | 0.80 | CNR2 (0.57) | ALDH1A1MEN1KMT2AL3MBTL1CNR2 | |
| SCHEMBL22215711 | 0.79 | ALDH1A1 (0.51) | APEX1ALDH1A1NPSR1TSHRMEN1 | |
| SCHEMBL25318908 | 0.78 | CNR2 (0.56) | ALDH1A1MEN1KMT2AL3MBTL1CNR2 | |
| SCHEMBL8862370 | 0.78 | CNR2 (0.56) | ALDH1A1MEN1KMT2AL3MBTL1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-20200369606-A1 | THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS | SHIKOKU CHEMICALS CORPORATION (JP) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369606-A1 | THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS | TMT1A, CTH, SLC7A11 | APEX1 53/4885ALDH1A1 81/4885NPSR1 2554/4885 |
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | TMT1A, CTH, SLC7A11 | APEX1 53/4885ALDH1A1 81/4885NPSR1 2554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.